Work

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

Year: 2018

Type: article

Source: Hepatology Research

DOI: 10.1111/hepr.13058

Authors: Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Tadashi Ikegami, Noritomo Shimada, Keizo Kato, Hiroshi Abe, Tomomi Okubo, Norio Itokawa, Chisa Kondo, Shigeru Mikami, Toru Asano, Yoshimichi Chuganji, Yasushi Matsuzaki, Hidenori Toyoda, Takashi Kumada, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri

Institutions: Chiba Hokusou Hospital, Nippon Medical School, Jikei University School of Medicine, Tokyo Medical University, Tokyo Medical University Ibaraki Medical Center, Otakanomori Hospital, Shinmatsudo Central General Hospital, Kikkoman (Japan), Tokyo Metropolitan Bokutoh Hospital, Ogaki Municipal Hospital, Nagoya City University

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Award: Integrating multiple omics analysis for understanding the pathological mechanism of chronic hepatitis B virus infection and identifying potential molecular targets using humanized chimeric mice

OpenAlex ID: W2783802128

FWCI: 2.845

Cites: 36

Cited by: 22

Related to: 10